泽璟制药-U
(688266)
| 流通市值：275.30亿 | | | 总市值：275.30亿 |
| 流通股本：2.65亿 | | | 总股本：2.65亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,218,105,122.56 | 2,031,180,276.61 | 2,070,253,178.01 | 2,117,480,591.46 |
| 交易性金融资产 | 465,530,630.04 | - | 16,202,207.73 | 33,972,692.65 |
| 应收票据及应收账款 | 187,928,977.51 | 154,252,012.65 | 178,322,601.4 | 175,399,720.05 |
| 其中：应收票据 | 2,996,390.25 | 3,029,214.25 | 33,570 | - |
| 应收账款 | 184,932,587.26 | 151,222,798.4 | 178,289,031.4 | 175,399,720.05 |
| 预付款项 | 68,169,270.6 | 44,992,292.23 | 47,610,994.58 | 47,256,101.22 |
| 其他应收款合计 | 10,532,125.81 | 10,271,230.89 | 10,473,035.7 | 9,741,045.61 |
| 存货 | 178,263,420.26 | 173,267,046.83 | 174,370,083.91 | 164,215,169.54 |
| 合同资产 | 2,648,010.82 | - | - | - |
| 其他流动资产 | 27,738,930.67 | 29,141,302.69 | 8,691,244.3 | 3,563,748.87 |
| 流动资产合计 | 3,158,916,488.27 | 2,443,104,161.9 | 2,505,923,345.63 | 2,551,629,069.4 |
| 非流动资产: | | | | |
| 固定资产 | 196,583,139.18 | 192,580,288.82 | 189,112,784.72 | 194,457,164.6 |
| 在建工程 | 283,160,268.01 | 275,930,391.26 | 248,998,132.79 | 152,531,961.67 |
| 使用权资产 | 15,455,643.77 | 17,375,222.18 | 18,689,490.38 | 19,141,912.99 |
| 无形资产 | 26,921,771.76 | 30,588,770.02 | 35,478,371.96 | 40,178,060.57 |
| 长期待摊费用 | 4,899,798.46 | 5,980,261.8 | 7,299,204.28 | 8,739,853.31 |
| 其他非流动资产 | 2,449,037.42 | 3,626,494.92 | 7,876,108.6 | 32,525,329.5 |
| 非流动资产合计 | 529,469,658.6 | 526,081,429 | 507,454,092.73 | 447,574,282.64 |
| 资产总计 | 3,688,386,146.87 | 2,969,185,590.9 | 3,013,377,438.36 | 2,999,203,352.04 |
| 流动负债: | | | | |
| 短期借款 | 842,994,687.63 | 989,050,579.42 | 966,944,810.81 | 976,363,228.04 |
| 应付票据及应付账款 | 265,097,688.67 | 244,162,944.44 | 223,894,825.33 | 195,242,184.05 |
| 其中：应付票据 | 50,959,797.52 | 22,468,876.58 | 20,512,200 | 17,637,650 |
| 应付账款 | 214,137,891.15 | 221,694,067.86 | 203,382,625.33 | 177,604,534.05 |
| 预收款项 | 61,162.08 | 84,097.86 | - | - |
| 合同负债 | 46,787,378.38 | 1,247,644.85 | 1,697,868.2 | 524,982.09 |
| 应付职工薪酬 | 55,764,589.78 | 77,148,573.05 | 62,431,883.94 | 66,171,395.63 |
| 应交税费 | 37,430,099.91 | 23,417,972.21 | 41,700,151.4 | 35,088,475.5 |
| 其他应付款合计 | 38,588,640 | 41,395,967.61 | 35,470,230.93 | 45,457,064.72 |
| 一年内到期的非流动负债 | 51,107,284.82 | 51,107,284.82 | 22,664,794.7 | 23,376,316.37 |
| 其他流动负债 | 689,953.64 | 324,810.06 | 50,936.04 | - |
| 流动负债合计 | 1,338,521,484.91 | 1,427,939,874.32 | 1,354,855,501.35 | 1,342,223,646.4 |
| 非流动负债: | | | | |
| 长期借款 | 83,999,999.96 | 83,999,999.96 | 125,699,999.96 | 125,699,999.96 |
| 租赁负债 | 7,512,212.61 | 8,597,765.62 | 10,358,629.52 | 13,140,162.19 |
| 递延收益 | 8,069,500 | 8,069,500 | 2,872,822.51 | 7,661,566.09 |
| 递延所得税负债 | 645,655.51 | 1,639,657.87 | 2,652,079.77 | 3,673,860.67 |
| 其他非流动负债 | 536,582,810.34 | 358,490,567.13 | 367,924,529.37 | 330,188,680.29 |
| 非流动负债合计 | 636,810,178.42 | 460,797,490.58 | 509,508,061.13 | 480,364,269.2 |
| 负债合计 | 1,975,331,663.33 | 1,888,737,364.9 | 1,864,363,562.48 | 1,822,587,915.6 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 264,708,186 | 264,708,186 | 264,708,186 | 264,708,186 |
| 资本公积 | 3,109,476,536.44 | 3,109,476,536.44 | 3,109,476,536.44 | 3,116,344,427.97 |
| 其他综合收益 | -14,054,159.76 | -14,047,844.8 | -15,012,183.49 | -14,891,154.47 |
| 未分配利润 | -1,647,076,079.14 | -2,279,688,651.64 | -2,210,158,663.07 | -2,189,546,023.06 |
| 归属于母公司股东权益合计 | 1,713,054,483.54 | 1,080,448,226 | 1,149,013,875.88 | 1,176,615,436.44 |
| 股东权益合计 | 1,713,054,483.54 | 1,080,448,226 | 1,149,013,875.88 | 1,176,615,436.44 |
| 负债和股东权益合计 | 3,688,386,146.87 | 2,969,185,590.9 | 3,013,377,438.36 | 2,999,203,352.04 |
| 公告日期 | 2026-04-29 | 2026-03-28 | 2025-10-31 | 2025-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |